Families lose trust after transplant foundation closure
OKLAHOMA CITY (KFOR) — It's been nearly a year since the National Foundation for Transplants closed. The organization helped patients come up with the necessary funds needed to get on a transplant list.
Almost a year later, some Integris Health patients feel like they can't trust another organization after the closure.
'We just don't have the trust to do that all over again,' said Pamela O'Brien, whose husband needs a kidney transplant.
'He is going to die': Oklahoma family impacted by transplant foundation closure
For nearly two years, Eric O'Brien has been waiting for a kidney transplant.
The family had almost $5,000 in their account with the National Foundation for Transplants, but that funding disappeared when the foundation suddenly closed last year.
'Nobody got their money back and everybody was just out that money,' said O'Brien.
The closure left the O'Brien's feeling uneasy about raising money with a different organization.
'We don't trust anymore. The hospital wants you to… have an organization. But we've said we'll raise some money ourselves one way or another. If he can get on the list, I will have the money…. I'll figure it out,' said O'Brien.
'It's a big shock': More Oklahomans impacted by transplant foundation closure
News 4 reached out to Integris for a comment on how the year has been without the NFT.
We continue to work closely with our patients during their transplant process. Since the closure of the National Foundation for Transplants in May 2024, we have added 207 patients to the national transplant waiting list. There are multiple mechanisms for patients who need additional funds to support a successful transplant. The specific avenue may be different depending upon the patient's unique needs. We are here for each individual patient, providing guidance and support throughout their transplant journey.
Integris Health
The O'Brien's are now raising money on their own, but are still scarred from the sudden loss less than a year ago.
'To have that money ripped away was just horrible. Not just from us, but from everybody. Like, there's so many emotions that go into that,' said Pamela O'Brien.
O'Brien said the family has a donation account set up for 'Eric O'Brien' at City National Bank, if you'd like to help the family.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
OSU researching Asian Longhorned Tick that can be deadly for cattle
STILLWATER, Okla. (KFOR) — A heads up for cattle producers, there's a deadly tick in the United States, and researchers at Oklahoma State University are concerned. Last year, a case was found in the Eastern part of the state. 'These ticks can be so high on a single cow that they can actually result in so much blood loss that the animal can die from that,' said Dr. Jonathan Cammack, Assistant Professor at OSU and State Extension Specialist for Livestock, Entomology, and Parasitology. Dr. Jonathan Cammack said the Asian Longhorned Tick, also known ALT is native to East Asia. It was first seen in the U.S. a decade ago, and in Oklahoma last year when it was discovered on cattle in Craig County. LOCAL NEWS: Neighbors blame school construction for ongoing drainage crisis 'It's not going to have that bright white spot on it like a lone star. And they're also going to be very small, about half the size of the normal tick that we're usually expecting to see at this time of year,' said Dr. Cammack. They're also concerned with how fast the ticks can reproduce. 'They can reproduce asexually so they don't have that added challenge of locating a mate in the environment,' said Dr. Cammack. Which means a female can lay up to 2,500 eggs on one animal and that can consume enough blood to be deadly. Now, they're hoping research can help with ideas to slow or stop the spread. 'There's a project going on at the vet school where they're collecting ticks that are suspected to be Asian Longhorned Ticks, and then they're testing them for the presence of this pathogen,' said Dr. Cammack. The pathogen they're testing for is the Theileria orientalis Ikeda genotype. This year, the team is looking for new cases of the tick, and they hope ranchers will help them with surveillance. LOCAL NEWS: 'He just stabbed me': New video shows Edmond officer stabbed during traffic stop 'It's just kind of, you know, being in tune with your animals, checking on them regularly, you know, not like you're saying every day, but you know, not also once a year either,' said Dr. Cammack. While they haven't seen any new cases in our state so far this year, the tick and pathogen are present in Arkansas, Missouri, and Kansas. If you see it on your cattle, call your local veterinarian or a local OSU Extension office so they can collect the ticks and get them tested. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
6 hours ago
- Yahoo
OKC VA preps for emergency operation exercise June 9
OKLAHOMA CITY (KFOR) – Officials with the Oklahoma City VA Medical Center announced on Friday an Emergency Operations Exercise is set to be conducted on June 9th. According to VA officials, the exercise operation will begin at 9:00 a.m. providing real life incidents ensuring mocking procedures are followed while providing help in the event of a mass casualty incident. 'This exercise will test the response capabilities of the OKC VA Medical Center Staff to a mass casualty event,' said Christopher Ence, Emergency Management Specialist. Service Oklahoma warns residents of text scam The VA says there will be no interruption to services during the exercise and if Veterans should not step in if they see staff participating. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Politico
15 hours ago
- Politico
WHO sounds the alarm as US measles cases mount
Presented by Driving The Day WHO SPEAKS UP ON MEASLES — President Donald Trump might not care for the World Health Organization's advice, but that isn't stopping one of its top officials from warning his administration about what's at stake as measles cases accumulate in the U.S. Dr. Katherine O'Brien, the WHO's vaccines director, told POLITICO's Carmen Paun that U.S. political leaders should clearly endorse and promote measles vaccination to prevent the country from losing its disease-elimination status — and become a location that gives rise to future outbreaks that can easily spread domestically and abroad among travelers. If the disease spreads continuously for a year, it would be considered endemic for the first time in 25 years. 'It's really a sign of a country going backwards in terms of their ability to protect people,' O'Brien said. Why it matters: O'Brien said 'leadership voices really matter' when people consider medical interventions for their children. If one family is influenced enough to decline the measles, mumps and rubella vaccine for their child, that's 'one child too many,' she said, given how highly contagious the virus is. Measles is 'not just a fever and a rash that people get over,' O'Brien said. So far this year, three unvaccinated people — including two young girls — have died from the disease in the U.S. Before the most recent outbreak, the last U.S. measles death occurred in 2015. Background: HHS Secretary Robert F. Kennedy Jr. has couched his promotion of the MMR shot with statements emphasizing that vaccination is a personal choice. Before he ran for president and then entered government, Kennedy founded Children's Health Defense, an anti-vaccine nonprofit that suggests shots cause a slew of pediatric medical problems such as autism, asthma and developmental delays. Kennedy has also inaccurately asserted that the MMR vaccine contains cells from aborted fetuses and has touted supplements like vitamin A as a disease treatment. HHS has defended the secretary's measles response, calling 'claims' that he's 'spreading misinformation or undermining vaccine confidence … flat-out false.' WELCOME TO FRIDAY PULSE. I'm FDA reporter Lauren Gardner, filling in for Kelly today. Pass along your tips, scoops and feedback to lgardner@ and khooper@ and follow along @Gardner_LM or @Kelhoops. POLITICO PRO SPACE — Need an insider's guide to the politics behind the new space race? From battles over sending astronauts to Mars to the ways space companies are vying to influence regulators, this weekly newsletter decodes the personalities, policy and power shaping the final frontier. Find out more. In Congress THIRD RAIL NO MORE? Senate Republicans are considering ways to incorporate Medicare cuts into their domestic spending package to help offset its cost — a move that could divide a party that can't afford many defections to pass the president's signature legislation, POLITICO's Jordain Carney, Meredith Lee Hill and Robert King report. The House version of President Donald Trump's big beautiful bill includes cuts to Medicaid, the government health insurance program for low-income people and those with disabilities. But cuts to Medicare — which insures those 65 and older — are widely seen as politically dangerous. The idea percolated in private meetings this week as GOP leaders try to placate budget hardliners who want more spending cuts in the package ahead of a self-imposed July 4 deadline for passage. And some Republicans believe Trump supports Medicare cuts — provided they're limited to targeting 'waste, fraud and abuse' — despite the potential for backlash from rank-and-file senators and House moderates who already sank efforts to touch the program. HEADING TO THE HUMPHREY BUILDING — The Senate confirmed Jim O'Neill on Thursday in a 52-43 vote to be HHS's deputy secretary, your morning host writes. O'Neill, a George W. Bush-era HHS official who's close with early Trump supporter and tech billionaire Peter Thiel, will be the department's No. 2 official charged with managing operations. AROUND THE AGENCIES FDA'S RARE DISEASE DRUG APPROACH — The FDA's leading biologics regulator said Thursday that he was open to using alternative measurement methods when evaluating rare-disease therapies, combining what he called 'gold-standard science and common sense' in the approval process. 'We will rapidly make available therapies at the first sign or promise of biomedical success or action, but we're also going to follow up overall survival and quality of life on the back end,' Dr. Vinay Prasad, director of the FDA's Center for Biologics Evaluation and Research, said during an agency roundtable on cell and gene therapies. The remarks were notable given Prasad's history of criticizing past FDA approvals of certain treatments, including a controversial Duchenne muscular dystrophy gene therapy and certain cancer drugs, using surrogate markers. Prasad added he's often asked whether he's 'solely' interested in randomized controlled trials and said he's open to a variety of methodologies demonstrating a drug's benefit. Background: His remarks come weeks after he and Commissioner Marty Makary unveiled a new Covid-19 vaccine framework that limits approvals of future formulation changes to people 65 and older and younger individuals with an underlying condition — and requiring new RCTs to prove the shots are safe and effective for young, healthy people. Cell and gene therapies are often discussed in the context of rare diseases as the technologies can address root causes instead of solely managing symptoms. But a condition's rarity hinders a company's ability to conduct a large-scale trial for a drug candidate, an issue with which regulators and industry have long struggled. The FDA launched a rare disease 'hub' last year to better align its drug and biologics regulators in their approach to considering those therapies for the market. NIH LOOKS TO AI — The National Institutes of Health is building an AI strategy to help HHS Secretary Robert F. Kennedy Jr. target chronic disease, POLITICO's Ruth Reader reports. Principal Deputy Director Matthew Memoli announced the plan Thursday, asking the public to weigh in at the Coalition for Health AI's Innovation Summit at Stanford University. NIH wants industry to comment on both the broad approach and the specific actions the administration should take in developing the strategy. The agency plans to create a new website to highlight its AI work. 'Addressing this crisis is going to require large-scale efforts — research that's going to generate large amounts of data — and we are going to need all the tools available to us in order to try to address this,' Memoli said. Names in the News Courtney Rhodes is now head of news and media relations at the U.S. Travel Association. She was previously a spokesperson at the FDA. The Health Resources and Services Administration announced its new 34-member board of directors for the Organ Procurement and Transplantation Network. WHAT WE'RE READING House FDA appropriators advanced their fiscal 2026 spending measure Thursday for the agency and the U.S. Department of Agriculture, POLITICO's David Lim reports. Infectious disease and other medical experts fear HHS's changes to Covid-19 vaccine recommendations will make it more difficult to immunize people by complicating discussions with providers and likely leading to fewer places stocking them, Stat's Helen Branswell writes.
